SCHEMBL7953705

SCHEMBL7953705

O=C(O)c1cc(-c2cccnc2)n2c1CCCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.43
KMO O15229 2/20 0.42
GAA P10253 1/20 0.41
AVPR2 P30518 1/20 0.41
OXTR P30559 1/20 0.41
AVPR1A P37288 1/20 0.41
MKNK1 Q9BUB5 2/20 0.40
MKNK2 Q9HBH9 2/20 0.40
DHODH Q02127 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
CYP11B2 P19099 4/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
CYP11B1 P15538 2/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7946521 0.96 KMO (0.46) CYP2C9KMOGAAMKNK1MKNK2
SCHEMBL2157288 0.89 MKNK1 (0.46) CYP2C9GAAAVPR2OXTRAVPR1A
SCHEMBL7946664 0.89 CYP11B2 (0.43) CYP2C9AVPR2OXTRAVPR1ACYP11B2
Hydrochloric Acid SCHEMBL10742608 0.88 CYP2C9 (0.39) CYP2C9GAAAVPR2OXTRAVPR1A
SCHEMBL7954905 0.86 NR4A2 (0.46) CYP11B2CYP11B1ALDH1A1MEN1KMT2A
SCHEMBL10742663 0.86 MKNK1 (0.45) CYP2C9GAAMKNK1MKNK2CYP11B2
SCHEMBL7953665 0.85 MKNK1 (0.47) MKNK1MKNK2CYP11B2KMT2A
Hydrochloric Acid SCHEMBL10737389 0.84 CYP11B2 (0.41) CYP2C9KMOMKNK1MKNK2CYP11B2
SCHEMBL10737507 0.82 CYP11B2 (0.47) MKNK1MKNK2CYP11B2CYP11B1CYP1A2
SCHEMBL7954951 0.81 HDAC3 (0.38) CYP2C9GAAAVPR2OXTRAVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194426-B1 CONTROLLING TUMOR NECROSIS FACTOR RHONA-POULENC RORER S.A. (FR) 2001-02-27 US disclosed
EP-0833635-A1 NOVEL USE FOR PYRROLE DERIVATIVES Aventis Pharma S.A. (FR) 1998-04-08 EP disclosed
WO-1997000073-A1 NOVEL USE FOR PYRROLE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1997-01-03 WO disclosed
US-4684658-A Anti-thrombotic ortho-condensed pyrrole derivatives, compositions, and method of use therefor RHONE-POULENC SANTE (FR) 1987-08-04 US disclosed